Editorial
doi: 10.1111/j.1365-2125.2010.03708.x.
From NCE to NICE: the role of pharmacoeconomics
- PMID: 20716229
- PMCID: PMC2949901
- DOI: 10.1111/j.1365-2125.2010.03708.x
Item in Clipboard
Editorial
From NCE to NICE: the role of pharmacoeconomics
Br J Clin Pharmacol.
2010 Sep.
No abstract available
Comment on
-
Value based pricing, research and development, and patient access schemes. Will the United Kingdom get it right or wrong?Br J Clin Pharmacol. 2010 Sep;70(3):360-6. doi: 10.1111/j.1365-2125.2010.03740.x. Br J Clin Pharmacol. 2010. PMID: 20716236 Free PMC article.
Similar articles
-
Pharmacoeconomics: NICE's approach to decision-making.Br J Clin Pharmacol. 2010 Sep;70(3):346-9. doi: 10.1111/j.1365-2125.2009.03589.x. Br J Clin Pharmacol. 2010. PMID: 20716233 Free PMC article. No abstract available.
-
Drugs, money and society (Part II).Br J Clin Pharmacol. 2010 Sep;70(3):342-5. doi: 10.1111/j.1365-2125.2009.03569.x. Br J Clin Pharmacol. 2010. PMID: 20716232 Free PMC article.
-
Pharmacoeconomics is coming of age.Clin Pharmacol Ther. 2008 Aug;84(2):188-90. doi: 10.1038/clpt.2008.120. Clin Pharmacol Ther. 2008. PMID: 18679179 No abstract available.
-
[Pharmacoeconomics in contemporary medicine].Pol Merkur Lekarski. 2004 May;16 Suppl 1:16-9. Pol Merkur Lekarski. 2004. PMID: 15524007 Review. Polish.
-
Why does NICE not recommend laparoscopic herniorraphy?BMJ. 2002 May 4;324(7345):1092-4. doi: 10.1136/bmj.324.7345.1092. BMJ. 2002. PMID: 11991919 Free PMC article. Review. No abstract available.
Cited by
-
Pharmacoeconomics.Br J Clin Pharmacol. 2012 Jun;73(6):968-72. doi: 10.1111/j.1365-2125.2012.04247.x. Br J Clin Pharmacol. 2012. PMID: 22360714 Free PMC article.
-
World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients.World J Methodol. 2014 Sep 26;4(3):163-88. doi: 10.5662/wjm.v4.i3.163. eCollection 2014 Sep 26. World J Methodol. 2014. PMID: 25332915 Free PMC article. Review.
-
Overview of healthcare in the UK.EPMA J. 2010 Dec;1(4):529-34. doi: 10.1007/s13167-010-0050-1. Epub 2010 Oct 25. EPMA J. 2010. PMID: 23199107 Free PMC article.
-
Role of the pharmacist in reducing healthcare costs: current insights.Integr Pharm Res Pract. 2017 Jan 25;6:37-46. doi: 10.2147/IPRP.S108047. eCollection 2017. Integr Pharm Res Pract. 2017. PMID: 29354549 Free PMC article. Review.
-
Cost-outcome description of clinical pharmacist interventions in a university teaching hospital.BMC Health Serv Res. 2014 Apr 17;14:177. doi: 10.1186/1472-6963-14-177. BMC Health Serv Res. 2014. PMID: 24742158 Free PMC article.
References
-
- Walley T. Drugs, money and society (Part II) Br J Clin Pharmacol. 2010 DOI: 10.1111/j.1365-2125.2009.03569.x. - DOI - PMC - PubMed
-
- Joint Royal Colleges of Physicians Training Board. Specialty training curriculum for Clinical Pharmacology and Therapeutics. August 2010. Available at http://www.jrcptb.org.uk/specialties/ST3-SpR/Documents/2010%20CPT%20Curr... (last accessed 14 June 2010)
-
- Edlin R, Round J, Hulme C, McCabe C. Cost effectiveness analysis and efficient use of the pharmaceutical budget: the key role of clinical pharmacologists. Br J Clin Pharmacol. 2010 DOI: 10.1111/j.1365-2125.2010.03617.x. - DOI - PMC - PubMed
-
- Hughes DA, Ferner RE. New drugs for old: disinvestment and NICE. BMJ. 2010;340:c572. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
